Nasze publikacje z zakresu pankreatologii

2022

Ocskay K, Juhász MF, Farkas N, Zádori N, Szakó L, Szakács Z, Szentesi A, Erőss B, Miklós E, Zemplényi A, Birkás B, Csathó Á, Hartung I, Nagy T, Czopf L, Izbéki F, Gajdán L, Papp M, Czakó L, Illés D, Marino MV, Mirabella A, Małecka-Panas E, Zatorski H, Susak Y, Opalchuk K, Capurso G, Apadula L, Gheorghe C, Saizu IA, Petersen OH, de-Madaria E, Rosendahl J, Párniczky A, Hegyi P; Hungarian Pancreatic Study Group. Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study. BMJ Open. 2022 Jan 4;12(1):e050821. doi: 10.1136/bmjopen-2021-050821. PMID: 34983758; PMCID: PMC8728419.

Jacek Tatur, Michał Lipiński, Marta Sznurkowska, Ewa Józefik, Grażyna Rydzewska Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study Adv Clin Exp Med . 2022 Apr;31(4):399-405. doi: 10.17219/acem/144993.

2021

Włodarczyk B, Borkowska A, Włodarczyk P, Małecka-Panas E, Gąsiorowska A. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes. Prz Gastroenterol. 2021;16(1):36-42. doi: 10.5114/pg.2020.95091. Epub 2020 May 9. PMID: 33986886; PMCID: PMC8112262.

Tarasiuk A, Mackiewicz T, Małecka-Panas E, Fichna J. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool? Cancer Biol Ther. 2021 Jun 3;22(5-6):347-356. doi: 10.1080/15384047.2021.1941584. Epub 2021 Jul 5. PMID: 34224317; PMCID: PMC8386725.

Gentiluomo M, Corradi C, Vanella G, Johansen AZ, Strobel O, Szentesi A, Milanetto AC, Hegyi P, Kupcinskas J, Tavano F, Neoptolemos JP, Bozzato D, Hackert T, Pezzilli R, Johansen JS, Costello E, Mohelnikova-Duchonova B, van Eijck CHJ, Talar-Wojnarowska R, Hansen CP, Darvasi E, Chen IM, Cavestro GM, Soucek P, Piredda L, Vodicka P, Gazouli M, Arcidiacono PG, Canzian F, Campa D, Capurso G. Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival.Sci Rep. 2021 Apr 7;11(1):7570. doi: 10.1038/s41598-021-87130-0.

Pistoni L, Gentiluomo M, Lu Y, López de Maturana E, Hlavac V, Vanella G, Darvasi E, Milanetto AC, Oliverius M, Vashist Y, Di Leo M, Mohelnikova-Duchonova B, Talar-Wojnarowska R, Gheorghe C, Petrone MC, Strobel O, Arcidiacono PG, Vodickova L, Szentesi A, Capurso G, Gajdán L, Malleo G, Theodoropoulos GE, Basso D, Soucek P, Brenner H, Lawlor RT, Morelli L, Ivanauskas A; PanGenEU Study investigators, Kauffmann EF, Macauda A, Gazouli M, Archibugi L, Nentwich M, Loveček M, Cavestro GM, Vodicka P, Landi S, Tavano F, Sperti C, Hackert T, Kupcinskas J, Pezzilli R, Andriulli A, Pollina L, Kreivenaite E, Gioffreda D, Jamroziak K, Hegyi P, Izbicki JR, Testoni SGG, Zuppardo RA, Bozzato D, Neoptolemos JP, Malats N, Canzian F, Campa D. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Carcinogenesis. 2021 Jul 3:bgab057. doi: 10.1093/carcin/bgab057. PMID: 34216462.

Peduzzi G, Gentiluomo M, Tavano F, Arcidiacono PG, Ermini S, Vodicka P, Boggi U, Cavestro GM, Capurso G, Morelli L, Milanetto AC, Pezzilli R, Lawlor RT, Carrara S, Lovecek M, Souček P, Guo F, Hackert T, Uzunoglu FG, Gazouli M, Párniczky A, Kupcinskas J, Bijlsma MF, Bueno-de-Mesquita B, Vermeulen R, van Eijck CHJ, Jamroziak K, Talar-Wojnarowska R, Greenhalf W, Gioffreda D, Petrone MC, Landi S, Archibugi L, Puzzono M, Funel N, Sperti C, Piredda ML, Mohelnikova-Duchonova B, Lu Y, Hlavac V, Gào X, Schneider M, Izbicki JR, Theodoropoulos G, Bunduc S, Kreivenaite E, Busch OR, Małecka-Panas E, Costello E, Perri F, Testoni SGG, Vanella G, Pasquali C, Oliverius M, Brenner H, Loos M, Götz M, Georgiou K, Erőss B, Maiello E, Szentesi A, Bazzocchi F, Basso D, Neoptolemos JP, Hegyi P, Kiudelis V, Canzian F, Campa D. Genetic polymorphisms involved in mitochondrial metabolism and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2021 Sep 15:cebp.0353.2021. doi: 10.1158/1055-9965.EPI-21-0353. PMID: 34526302.

Lu Y, Gentiluomo M, Macauda A, Gioffreda D, Gazouli M, Petrone MC, Kelemen D, Ginocchi L, Morelli L, Papiris K, Greenhalf W, Izbicki JR, Kiudelis V, Mohelníková-Duchoňová B, Bueno-de-Mesquita B, Vodicka P, Brenner H, Diener MK, Pezzilli R, Ivanauskas A, Salvia R, Szentesi A, Aoki MN, Németh BC, Sperti C, Jamroziak K, Chammas R, Oliverius M, Archibugi L, Ermini S, Novák J, Kupcinskas J, Strouhal O, Souček P, Cavestro GM, Milanetto AC, Vanella G, Neoptolemos JP, Theodoropoulos GE, van Laarhoven HWM, Mambrini A, Moz S, Kala Z, Loveček M, Basso D, Uzunoglu FG, Hackert T, Testoni SGG, Hlaváč V, Andriulli A, Lucchesi M, Tavano F, Carrara S, Hegyi P, Arcidiacono PG, Busch OR, Lawlor RT, Puzzono M, Boggi U, Guo F, Małecka-Panas E, Capurso G, Landi S, Talar-Wojnarowska R, Strobel O, Gao X, Vashist Y, Campa D, Canzian F. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Front Oncol. 2021 Dec 3;11:771312. doi: 10.3389/fonc.2021.771312. PMID: 34926279; PMCID: PMC8678088.

Gullo’s syndrome - what do we know?. [AUT.] ANNA RYCYK, PAULINA FURTAK, AGNIESZKA MĄDRO, BEATA KASZTELAN-SZCZERBIŃSKA, HALINA CICHOŻ-LACH. Prz. Gastroenterol. 2021 vol. 16 nr 3 s. 181-183, bibliogr. poz. 23.

Martyna Rozek, Michal Lipinski, Ewa Jozefik, Zuzanna Znajdek, Marta Kiziak, Marta Sznurkowska, Jacek Tatur, Malgorzata Degowska, Grazyna Rydzewska Pancreatic cystic lesions in diabetes mellitus patients Prz Gastroenterol . 2021;16(1):62-66. doi: 10.5114/pg.2020.96080. Epub 2020 Jun 4.

2020

Włodarczyk B, Borkowska A, Wlodarczyk P, Malecka-Panas E, Gasiorowska A. Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma. J Clin Gastroenterol. 2020 Oct;54(9):e83-e88. doi: 10.1097/MCG.0000000000001297. PMID: 31851103.

Wos-Wroniewicz E, Caban M, Malecka-Panas E. Role of adipokines in the assessment of severity and predicting the clinical course of acute pancreatitis. J Physiol Pharmacol. 2020 Oct;71(5). doi: 10.26402/jpp.2020.5.01. PMID: 33475088.

Campa D, Gentiluomo M, Obazee O, Ballerini A, Vodickova L, Hegyi P, Soucek P, Brenner H, Milanetto AC, Landi S, Gao X, Bozzato D, Capurso G, Tavano F, Vashist Y, Hackert T, Bambi F, Bursi S, Oliverius M, Gioffreda D, Schöttker B, Ivanauskas A, Mohelnikova-Duchonova B, Darvasi E, Pezzilli R, Małecka-Panas E, Strobel O, Gazouli M, Katzke V, Szentesi A, Cavestro GM, Farkas G Jr, Izbicki JR, Moz S, Archibugi L, Hlavac V, Vincze Á, Talar-Wojnarowska R, Rusev B, Kupcinskas J, Greenhalf B, Dijk F, Giese N, Boggi U, Andriulli A, Busch OR, Vanella G, Vodicka P, Nentwich M, Lawlor RT, Theodoropoulos GE, Jamroziak K, Zuppardo RA, Moletta L, Ginocchi L, Kaaks R, Neoptolemos JP, Lucchesi M, Canzian F. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Int J Cancer 2020; 147(8): 2065-2074.

Talar-Wojnarowska R, Wozniak M, Borkowska A, Olakowski M, Malecka-Panas E. Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss. J Physiol Pharmacol2020;71(1): 105-112 doi:10.26402/jpp.2020.1.10

Galeotti AA, Gentiluomo M, Rizzato C, Obazee O, Neoptolemos JP, Pasquali C, Nentwich M, Cavestro GM, Pezzilli R, Greenhalf W, Holleczek B, Schroeder C, Schöttker B, Ivanauskas A, Ginocchi L, Key TJ, Hegyi P, Archibugi L, Darvasi E, Basso D, Sperti C, Bijlsma MF, Palmieri O, Hlavac V, Talar-Wojnarowska R, Mohelnikova-Duchonova B, Hackert T, Vashist Y, Strouhal O, van Laarhoven H, Tavano F, Lovecek M, Dervenis C, Izbéki F, Padoan A, Małecka-Panas E, Maiello E, Vanella G, Capurso G, Izbicki JR, Theodoropoulos GE, Jamroziak K, Katzke V, Kaaks R, Mambrini A, Papanikolaou IS, Szmola R, Szentesi A, Kupcinskas J, Bursi S, Costello E, Boggi U, Milanetto AC, Landi S, Gazouli M, Vodickova L, Soucek P, Gioffreda D, Gemignani F, Brenner H, Strobel O, Büchler M, Vodicka P, Paiella S, Canzian F, Campa D. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. J Med Genet. 2020 Jun 26:jmedgenet-2020-106961. doi: 10.1136/jmedgenet-2020-106961

Talar-Wojnarowska R, Woźniak M, Borkowska A, Cypryk K, Olakowski M, Małecka-Panas E. Procoagulant disorders in patients with newly diagnosed pancreatic adenocarcinoma. Medicina 2020; 56, 677; doi:10.3390/medicina56120677

Kaune T, Ruffert C, Hesselbarth N, Damm M, Krug S, Cardinal von Widdern J, Masson E, Chen JM, Rebours V, Buscail L, Férec C, Grützmann R, Te Morsche RHM, Drenth JP, Cavestro GM, Zuppardo RA, Saftoiu A, Malecka-Panas E, Głuszek S, Bugert P, Lerch MM, Sendler M, Weiss FU, Zou WB, Deng SJ, Liao Z, Scholz M, Kirsten H, Hegyi P, Witt H, Michl P, Griesmann H, Rosendahl J. Analysis of GPRC6A variants in different pancreatitis etiologies. Pancreatology. 2020 Oct;20(7):1262-1267. doi: 10.1016/j.pan.2020.08.001. PMID: 32859544.

The influence of erythropoietin on apoptosis and fibrosis in the early phase of chronic pancreatitis in rats. [AUT.] WERONIKA KAŹMIERAK*, AGNIESZKA KOROLCZUK, JACEK KURZEPA, GRAŻYNA CZECHOWSKA, ANNA BOGUSZEWSKA-CZUBARA, AGNIESZKA MĄDRO. Arch. Med. Sci. 2021 vol. 17 nr 4 s. 1100-1108, bibliogr. poz. 57. DOI: 10.5114/aoms.2020.99800

Malnutrition in chronic pancreatitis: causes, assessment methods, and therapeutic management. [AUT.] AGNIESZKA MĄDRO. Can. J. Gastroenterol. Hepatol. [online] 2020 vol. 2020 [art. ID] 8875487, s. 1-6, bibliogr. poz. 34, [przeglądany 3 września 2020]. Dostępny w: https://www.hindawi.com/journals/cjgh/2020/8875487/. DOI: 10.1155/2020/8875487

Gullo’s Syndrome - case report. [AUT.] ANNA RYCYK*, PAULINA FURTAK, AGNIESZKA MĄDRO, BEATA KASZTELAN-SZCZERBIŃSKA, HALINA CICHOŻ-LACH. J. Pre-Clin. Clin. Res. [online] 2020 vol. 14 nr 4 s. 117-119, bibliogr, [przeglądany 2 października 2020]. Dostępny w: http://www.jpccr.eu/Gullo-s-Syndrome-case-report,127792,0,2.html. DOI: 10.26444/jpccr/127792

Serum miR 210 3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis. [AUT.] MAŁGORZATA GUZ*, WITOLD JELENIEWICZ, MAREK CYBULSKI, JOANNA KOZICKA, JACEK KURZEPA, AGNIESZKA MĄDRO. Biomed. Rep. [online] 2021 vol. 14 nr 1 [art. nr] 10, s. 1-6, bibliogr. poz. 43, [przeglądany 24 listopada 2020]. Dostępny w: https://doi.org/10.3892/br.2020.1386. DOI: 10.3892/br.2020.1386

Michał Lipiński, Grażyna Rydzewska Acute pancreatitis and the weekend effect: does weekend admission affect patient outcome? Prz. Gastroenterol. 2020;15(3):241-246. doi: 10.5114/pg.2020.95039. Epub 2020 Sep 19.

2019

Winter K, Talar-Wojnarowska R, Dąbrowski A, Degowska M, Durlik M, Gąsiorowska A, Głuszek S, Jurkowska G, Kaczka A, Lampe P, Marek T, Nasierowska-Guttmejer A, Nowakowska-Duława E, Rydzewska G, Strzelczyk J, Śledziński Z, Małecka-Panas E. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Prz Gastroenterol. 2019;14(1):1-18. doi: 10.5114/pg.2019.83422. Epub 2019 Mar 12. PMID: 30944673; PMCID: PMC6444110.

Kaune T, Hollenbach M, Keil B, Chen JM, Masson E, Becker C, Damm M, Ruffert C, Grützmann R, Hoffmeister A, Te Morsche RHM, Cavestro GM, Zuppardo RA, Saftoiu A, Malecka-Panas E, Głuszek S, Bugert P, Lerch MM, Weiss FU, Zou WB, Liao Z, Hegyi P, Drenth JP, Riedel J, Férec C, Scholz M, Kirsten H, Tóth A, Ewers M, Witt H, Griesmann H, Michl P, Rosendahl J. Common variants in glyoxalase I do not increase chronic pancreatitis risk. PLoS One. 2019 Oct 29;14(10):e0222927. doi: 10.1371/journal.pone.0222927. PMID: 31661534; PMCID: PMC6818803.

Gentiluomo M, García PP, Galeotti AA, Talar-Wojnarowska R, Tjaden C, Tavano F, Strobel O, Kupcinskas J, Neoptolemos J, Hegyi P, Costello E, Pezzilli R, Sperti C, Lawlor RT, Capurso G, Szentesi A, Soucek P, Vodicka P, Lovecek M, Hackert T, Cavestro GM, Milanetto AC, Canzian F, Daniele C. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.Carcinogenesis. 2019 Jan 9. doi: 10.1093/carcin/bgz006.

Obazee O, Archibugi L, Andriulli A, Soucek P, Małecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor RT, Cavestro GM, Milanetto AC, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu CE, Gheorghe C, Theodoropoulos GE, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen JS, Bojesen SE, Chen I, Jensen BV, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki JR, Cuk K, Saum KU, Cantore M, Kupcinskas J, Palmieri O, Fave GD, Landi S, Salvia R, Fogar P, Vashist YK, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian F. Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma. Int J Cancer 2019 2019;145 (3):686-693. doi: 10.1002/ijc.32127.

Párniczky A, Lantos T, Tóth EM, Szakács Z, Gódi S, Hágendorn R, Illés D, Koncz B, Márta K, Mikó A, Mosztbacher D, Németh BC, Pécsi D, Szabó A, Szücs Á, Varjú P, Szentesi A, Darvasi E, Erőss B, Izbéki F, Gajdán L, Halász A, Vincze Á, Szabó I, Pár G, Bajor J, Sarlós P, Czimmer J, Hamvas J, Takács T, Szepes Z, Czakó L, Varga M, Novák J, Bod B, Szepes A, Sümegi J, Papp M, Góg C, Török I, Huang W, Xia Q, Xue P, Li W, Chen W, Shirinskaya NV, Poluektov VL, Shirinskaya AV, Hegyi PJ, Bátovský M, Rodriguez-Oballe JA, Salas IM, Lopez-Diaz J, Dominguez-Munoz JE, Molero X, Pando E, Ruiz-Rebollo ML, Burgueño-Gómez B, Chang YT, Chang MC, Sud A, Moore D, Sutton R, Gougol A, Papachristou GI, Susak YM, Tiuliukin IO, Gomes AP, Oliveira MJ, Aparício DJ, Tantau M, Kurti F, Kovacheva-Slavova M, Stecher SS, Mayerle J, Poropat G, Das K, Marino MV, Capurso G, Małecka-Panas E, Zatorski H, Gasiorowska A, Fabisiak N, Ceranowicz P, Kuśnierz-Cabala B, Carvalho JR, Fernandes SR, Chang JH, Choi EK, Han J, Bertilsson S, Jumaa H, Sandblom G, Kacar S, Baltatzis M, Varabei AV, Yeshy V, Chooklin S, Kozachenko A, Veligotsky N, Hegyi P; Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations. Pancreatology. 2019 Jun;19(4):488-499. doi: 10.1016/j.pan.2019.04.003. Epub 2019 Apr 19. PMID: 31068256.

2018

Kadaj-Lipka R, Lipiński M, Adrych K, Durlik M, Gąsiorowska A, Jarosz M, Jurkowska G, Małecka-Panas E, Oracz G, Rosołowski M, Skrzydło-Radomańska B, Talar-Wojnarowska R, Rydzewska G. Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club. Prz Gastroenterol 2018;13(3):167-181.

Wlodarczyk B, Gasiorowska A, Malecka-Panas E. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC). J Clin Gastroenterol. 2018 Aug;52(7):569-572. doi: 10.1097/MCG.0000000000001073. PMID: 29912760.

Campa D, Pastore M, Capurso G, Hackert T, Di Leo M, Izbicki JR, Khaw KT, Gioffreda D, Kupcinskas J, Pasquali C, Macinga P, Kaaks R, Stigliano S, Peeters PH, Key TJ, Talar-Wojnarowska R, Vodicka P, Valente R, Vashist YK, Salvia R, Papaconstantinou I, Shimizu Y, Valsuani C, Zambon CF, Gazouli M, Valantiene I, Niesen W, Mohelnikova-Duchonova B, Hara K, Soucek P, Malecka-Panas E, Bueno-De-Mesquita HB, Johnson T, Brenner H, Tavano F, Fogar P, Ito H, Sperti C, Butterbach K, Latiano A, Andriulli A, Cavestro GM, Busch ORC, Dijk F, Greenhalf W, Matsuo K, Lombardo C, Strobel O, König AK, Cuk K, Strothmann H, Katzke V, Cantore M, Mambrini A, Oliverius M, Pezzilli R, Landi S, Canzian F. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Int J Cancer 2018 Jan 15;142(2):290-296

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Liço V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantù C, Malecka-Panas E, Landi S, Neoptolemos JP, Basso D, Talar-Wojnarowska R, Rinzivillo M, Andriulli A, Canzian F, Campa D. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms. Carcinogenesis 2018; 39:360-367

Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Capurso G, Mohelnikova-Duchonova B, Khaw KT, König AK, Kupcinskas J, Kaaks R, Bambi F, Archibugi L, Mambrini A, Cavestro GM, Landi S, Hegyi P, Izbicki JR, Gioffreda D, Zambon CF, Tavano F, Talar-Wojnarowska R, Jamroziak K, Key TJ, Fave GD, Strobel O, Jonaitis L, Andriulli A, Lawlor RT, Pirozzi F, Katzke V, Valsuani C, Vashist YK, Brenner H, Canzian F. Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study. Int J Cancer. 2018 Oct 16. doi: 10.1002/ijc.31928.

Talar-Wojnarowska R, Durko Ł, Woźniak M, Kujawiak M, Grzegorczyk J, Olakowski M, Lampe P, Małecka-Panas E. Clinical significance of cathelicidin antimicrobial peptide in patients with pancreatic cancer. Post N Med 2018; 31(2A): 8-12

2017

Barbara Wlodarczyk, Anita Gasiorowska, Anna Borkowska, Ewa Malecka-Panas: Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC), Pancreatology 17 (2017) 623-628

Oracz G, Pertkiewicz J, Dadalski M, Lipinski P, Wojno W, Tesseire M,Woynarowski M.: Complications of endoscopic retrograde cholangiopancreatography in children with chronic pancreatitis depends on center experience. J Pediatr. 2017

Mar 20. pii: S0022-3476(17)30342-6.Kujko AA, Berki DM, Oracz G, Wejnarska K, Antoniuk J, Wertheim-Tysarowska K, Kołodziejczyk E, Bal J, Sahin-Tóth M, Rygiel AM. A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis. Gut. 2017 Mar 3. pii: gutjnl-2017-313816.

Michał Lipiński, Grażyna Rydzewska Zapobieganie ostremu zapaleniu trzustki w czasie cholangiopankreatografii wstecznej ― czy już wszystko jasne? Gastroenterologia Kliniczna 2017;9(2):33-39

Kujko AA, Berki DM, Oracz G, Wejnarska K, Antoniuk J, Wertheim-Tysarowska K, Kołodziejczyk E, Bal J, Sahin-Tóth M, Rygiel AM. A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis. Gut. 2017 Mar 3. pii: gutjnl-2017-313816.

Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, et al. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity. Pancreatology. 2017 Jan - Feb;17(1):24-29.

Michał Lipiński, Grażyna Rydzewska Immature granulocytes predict severe acute pancreatitis (AP) independently of systemic inflammatory response syndrome (SIRS). Gastroenterology Rev 2017; 12 (2): 140–144

Lipinski M, Degowska M, Rydzewska G. Cystic fluid neutrophil gelatinase-associated lipocalin (NGAL) concentration in differential diagnosis of pancreatic cystic lesions: a new factor enters the scene?. Gastroenterology Review 2017. doi:10.5114/pg.2017.68805.

Beatrice Mohelnikova-Duchonova, Ondrej Strouhal, David J. Hughes, Ivana Holcatova, Martin Oliverius, Zdenek Kala, Daniele Campa, Cosmeri Rizzato, Federico Canzian, Raffaele Pezzilli, Renata Talar-Wojnarowska, Ewa Malecka-Panas, Cosimo Sperti, Carlo Federico Zambon, Sergio Pedrazzoli, Paola Fogar, Anna Caterina Milanetto, Gabriele Capurso, Gianfranco Delle Fave, Roberto Valente, Maria Gazouli, Giuseppe Malleo, Rita Teresa Lawlor, Oliver Strobel, Thilo Hackert, Nathalia Giese, Pavel Vodicka, Ludmila Vodickova, Stefano Landi, Francesca Tavano, Domenica Gioffreda, Ada Piepoli, Valerio Pazienza, Andrea Mambrini, Mariangela Pedata, Maurizio Cantore, Franco Bambi25, Stefano Ermini25, Niccola Funel,Radmila Lemstrova & Pavel Soucek. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival Scientific reports 2017

Rosendahl J., Kursten H., Hegyi E., Malecka-Panas E et al Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.Gut, 2017

Issa Y., Hjalmar Santvoort, Fockens P et al Doagnosis and treatment in chronic pancreatitis:an international survey and case vignette study.HPB, 2017

Durko Ł., Włodarski W., Stasikowska-Kanicka O., Wągrowska-Danilewicz M., Danilewicz M., Hogendorf P., Strzelczyk J, Małecka-Panas E.Expression and Clinical significance of cancer stem cel markers CD24, CD44 and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis, Disease Markers, 2017

Obazee O., Capurso G., Tavano F, Małecka-Panas E, Talar-Wojnarowska R.Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.Carcinogenesis, 2017, 1-8

2016

Koziel D, Gluszek S, Osuch MG: Course of acute pancreatitis in diabetic patients. Ann Ital Chir. 2016; 87:18-22.

Rosołowski M, Lipiński M, Dobosz M, Durlik M, Głuszek S, Kuśnierz K, Lampe P, Małecka-Panas E, Nowakowska-Duława E, Nowak-Niezgoda M, Radomańska B, Talar-Wojnarowska R, Wereszczyńska-Siemiątkowska U, Rydzewska G., Management of acute pancreatitis (AP) - Polish Pancreatic Club recommendations, Prz Gastroenterol. 2016;11(2):65-72.

Madro A, Kurzepa J, Celinski K, Slomka M, Czechowska G, Kurzepa J, Kazmierak W, Buszewicz G, Ciesielka M, Madro R, Effects of renin-angiotensin system inhibitors on fibrosis in patients with alcoholic chronic pancreatitis, J Physiol Pharmacol. 2016 Feb;67(1):103-10.

Sporek M, Dumnicka P, Gala-Bladzinska A, Ceranowicz P, Warzecha Z, Dembinski A, Stepien E, Walocha J, Drozdz R, Kuzniewski M, Kusnierz-Cabala B. Angiopoietin-2 Is an Early Indicator of Acute Pancreatic-Renal Syndrome in Patients with Acute Pancreatitis. Mediators Inflamm. 2016;2016:5780903.

Bukowczan J, Cieszkowski J, Warzecha Z, Ceranowicz P, Kusnierz-Cabala B, Tomaszewska R, Dembinski A. Therapeutic Effect of Obestatin in the Course of Cerulein-Induced Acute Pancreatitis. Pancreas. 2016 May-Jun;45(5):700-6.

Degowska M, Rydzewska G, Incydentaloma w trzustce – zasady postępowania, ze szczególnym uwzględnieniem zmian torbielowatych, Terapia, Nr 10 (344), październik 2016, s. 64-67

Kołodziejczyk E, Wejnarska K, Oracz G. Autoimmune pancreatitis in the paediatric population - review of the literature and own experience. Dev Period Med. 2016;20(4):279-286.

Wejnarska K, Kołodziejczyk E, Ryżko J, Oracz G. Comparison of 72-hour fecal fat quantification and the 13C-mixed triglyceride breath test in assessing pancreatic exocrine sufficiency in children with chronic pancreatitis. Dev Period Med. 2016;20(3):222-227.

Wejnarska K, Kolodziejczyk E, Wertheim-Tysarowska K, Dadalski M, Sobczynska-Tomaszewska A, Kierkus J, Bal J, Rygiel AM, Oracz G. The Etiology and Clinical Course of Chronic Pancreatitis in Children With Early Onset of the Disease. J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):665-670.

Oracz G, Kolodziejczyk E, Sobczynska-Tomaszewska A, Wejnarska K, Dadalski M, Grabarczyk AM, Kierkus J, Woynarowski M, Wertheim-Tysarowska K, Ryzko J, Bal J, Rygiel AM. The clinical course of hereditary pancreatitis in children – A comprehensive analysis of 41 cases. Pancreatology. 2016 Jul-Aug;16(4):535-41.

Oracz G, Kolodziejczyk E, Wejnarska K, Kierkus J. Toxic-metabolic Risk Factors in Pediatric Chronic Pancreatitis-Single Center Experience. J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):e66.

Barbara Włodarczyk, Ewa Małecka-Panas: Nowości z zakresu chorób trzustki przedstawione na Konferencji Naukowej Amerykańskiego Towarzystwa Gastroenterologicznego „Digestive Disease Week 2016” w San Diego, Lekarz POZ 3/2016, s. 163-169

Talar-Wojnarowska R, Gąsiorowska A, Olakowski M, Dranka-Bojarowska D, Lampe P, Smolarz B, Małecka-Panas E. Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer. Biomed Rep 2016; 4(2): 236-240.

Gasiorowska A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E. Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. Dig Dis Sci 2016; 61(4):1121-9.

Kozak A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E, Gąsiorowska A. Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis

Rizzato C, Campa D, Talar-Wojnarowska R, Halloran C, Kupcinskas J, Butturini G, Mohelníková-Duchoňová B, Sperti C, Tjaden C, Ghaneh P, Hackert T, Funel N, Giese N, Tavano F, Pezzilli R, Pedata M, Pasquali C, Gazouli M, Mambrini A, Souček , di Sebastiano P, Capurso G, Cantore M, Oliverius M, Offringa R, Małecka-Panas E, Strobel O, Scarpa A, Canzian F.

Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.Carcinogenesis 2016,37,10, 957-64

Daniele Campa, Manuela Pastore, Manuel Gentiluomo, Renata Talar- Wojnarowska, Juozas Kupcinskas, Ewa Malecka-Panas, John P. Neoptolemos, Willem Niesen, Pavel Vodicka, Gianfranco Delle Fave, H. Bas Bueno-de- Mesquita, Maria Gazouli, Paola Pacetti, Milena Di Leo, Hidemi Ito, Harald Klüter, Pavel Soucek, Vincenzo Corbo, Kenji Yamao, Satoyo Hosono, Rudolf Kaaks, Yogesh Vashist, Domenica Gioffreda, Oliver Strobe, Yasuhiro Shimizu, Frederike Dijk, Angelo Andriulli, Audrius Ivanauskas, Peter Bugert, Francesca Tavano, Ludmila Vodickova, Carlo Federico Zambon, Martin Lovecek, Stefano Landi, Timothy J. Key, Ugo Boggi, Raffaele Pezzilli, Krzysztof Jamroziak, Beatrice Mohelnikova-Duchonova, Andrea Mambrini, Franco Bambi, Olivier Busch, Valerio Pazienza, Roberto Valente, George E. Theodoropoulos, Thilo Hackert, Gabriele Capurso9, Giulia Martina Cavestro, Claudio Pasquali, Daniela Basso, Cosimo Sperti, Keitaro Matsuo, Markus Büchler, Kay-Tee Khaw, Jakob Izbicki, Eithne Costello, Verena Katzke, Christoph Michalski, Anna Stepien, Cosmeri Rizzato, Federico Canzian. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk .Oncotarget,2016,7,35,57011-57020

Martinez-Moneo E., Stigliano S., Hedstrom A., Kaczka A., Malvik M., Waldthaler A., Maissoneuve P., Simon P., Capurso G.Deficiency of fat-soluble vitamins in chronic pancreatitis:A systemic review and meta-analysis.Pancreatology, 2016, 1-7

Zhang M., Wang A , Obazee O I wsp.Three new pancreatic cancer susceptibility signals identified on chroosomes 1q32.1, 5pp15.33 and 8Q24.21.Oncotarget, 2016,7, 41, 66328-66343

Daniele Campa, Gabriele Capurso, Manuela Pastore, Renata Talar-Wojnarowska,Anna Caterina Milanetto, Luca Landoni, Evaristo Maiello, Rita T. Lawlor, Ewa Malecka-Panas, Niccola Funel, Maria Gazouli, Antonio De Bonis, Harald Klüter, Maria Rinzivillo,Gianfranco Delle Fave, Thilo Hackert, Stefano Landi, Peter Bugert, Franco Bambi,Livia Archibugi, Aldo Scarpa, Verena Katzke, Christos Dervenis1 Valbona Liço,Sara Furlanello, Oliver Strobel, Francesca Tavano, Daniela Basso, Rudolf Kaaks,Claudio Pasquali, Manuel Gentiluomo, Cosmeri Rizzato & Federico Canzian. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.Scientific Reports, 2016 Dec 23;6:39565

2015

Dorota Koziel, Stanislaw Gluszek, Jaroslaw Matykiewicz, Piotr Lewitowicz, Zuzanna Drozdzak: Comparative analysis of selected scales to assess of prognosis in acute pancreatitis. Can J Gastroenterol Hepatol 2015; 29(6):299-303

Koziel D, Gluszek S, Kowalik A, Chlopek M, Pieciak L Genetic mutations in SPINK1, CFTR, CTRC genes in acute pancreatitis. BMC Gastroenterol. 2015 Jun 23;15:70. doi: 10.1186/s12876-015-0302-6.

Głuszek S., Matykiewicz J., Kozieł D., Klimer D., Wawrzycka I., Ogonowska A.: Risk Factors Of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography - A Retrospective Cohort Study. Polski Przegląd Chirurgiczny 2015; 87 (10): 499-505.

Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, Rydzewska G. : Fluid resuscitation in acute pancreatitis: Normal saline or lactated Ringer's solution? World J Gastroenterol. 2015 Aug 21;21(31):9367-72.

Miskiewicz A, Szparecki G, Durlik M, Rydzewska G, Ziobrowski I, Górska R.: The Q705K and F359L Single-Nucleotide Polymorphisms of NOD-Like Receptor Signaling Pathway: Association with Chronic Pancreatitis, Pancreatic Cancer, and Periodontitis. Arch Immunol Ther Exp (Warsz). 2015 Dec;63(6):485-94.

Lipinski M, Rydzewska-Rosolowska A, Rydzewski A, Rydzewska G.: Urinary neutrophil gelatinase-associated lipocalin as an early predictor of disease severity and mortality in acute pancreatitis. Pancreas. 2015 Apr;44(3):448-52.

Beata Stępień, Grażyna Rydzewska,: Dynamika zmian fibrynogenu w prognozowanym lekkim i cieżkim zapaleniu trzustki u ludzi, Postępy Nauk Medycznych, t. XXVIII, nr 8B, 2015, s. 42-47.

Durlik M. Konsensus międzynarodowej grupy badawczej chirurgii trzustki. Medical Probl. 2015; 51(2):6-9. Praca poglądowa

Durlik M, Baumgart K. : Pobranie i przeszczepienie trzustki i trzustki z nerką – aspekty chirurgiczne w: „Transplantologia kliniczna. Przeszczepy narządowe”. pod red. L. Cierpki, M. Durlik. Wydawnictwo Termedia 2015, ISBN 978-83—7988-012-6, rozdział w książce str. 398-407

Warzecha Z, Sendur P, Ceranowicz P, Dembinski M, Cieszkowski J, Kusnierz-Cabala B, Tomaszewska R, Dembinski A.. Pretreatment with low doses of acenocoumarol inhibits the development of acute ischemia/reperfusion-induced pancreatitis. J Physiol Pharmacol. 2015 Oct;66(5):731-40.

Bukowczan J, Warzecha Z, Ceranowicz P, Kuśnierz-Cabala B, Tomaszewska R. Obestatin Accelerates the Recovery in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats. PLoS One. 2015 Jul 30;10(7):e0134380.

Bukowczan J, Warzecha Z, Ceranowicz P, Kuśnierz-Cabala B, Tomaszewska R, Dembinski A. Pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats. Eur J Pharmacol. 2015 Aug 5;760:113-21.

Bukowczan J, Warzecha Z, Ceranowicz P, Kusnierz-Cabala B, Tomaszewska R, Dembinski A. Therapeutic effect of ghrelin in the course of ischemia/reperfusion-induced acute pancreatitis. Curr Pharm Des. 2015;21(17):2284-90.

Ceranowicz P, Warzecha Z, Dembinski A. Peptidyl hormones of endocrine cells origin in the gut--their discovery and physiological relevance. J Physiol Pharmacol. 2015 Feb;66(1):11-27.

Ceranowicz P, Cieszkowski J, Warzecha Z, Dembiński A. Experimental models of acute pancreatitis. Postepy Hig Med Dosw (Online). 2015 Feb 21;69:264-9.

Ceranowicz P, Cieszkowski J, Warzecha Z, Kuśnierz-Cabala B, Dembiński A. The Beginnings of Pancreatology as a Field of Experimental and Clinical Medicine. Biomed Res Int. 2015;2015:128095.

Madro A, Ciesielka M, Celinski K, Slomka M, Czechowska G, Kurzepa J, Kaszelan-Szczerbinska B, Buszewicz G, Madro R., The genetic predisposition and its impact on the diabetes mellitus development in patients with alcoholic chronic pancreatitis, Gastroenterol Res Pract. 2015;2015:309156.

Barbara Włodarczyk, Anna Borkowska, Leszek Czupryniak, Ewa Małecka-Panas, Anita Gąsiorowska: Powstawanie zaburzeń gospodarki węglowodanowej w przebiegu raka gruczołowego trzustki (RT) i przewlekłego zapalenia trzustki (PZT) – ocena insulinemii i insulinooporności, Postępy Nauk Medycznych, t. XXVIII, nr 5, 2015, 304-311

Barbara Włodarczyk , Ludomir Stefańczyk, Ewa Małecka-Panas, Anita Gąsiorowska: Powikłania naczyniowe w przebiegu ostrego i przewlekłego zapalenia trzustki, Postępy Nauk Medycznych, t. XXVIII, nr 8B, 2015, s. 16-22

Rygiel AM, Wojnicka-Stolarz M, Niepokój K, Oracz G, Bal J, Wertheim-Tysarowska K, Gutkowski K. CHRONIC PANCREATITIS IN A PATIENT WITH THE p.Asn34Ser HOMOZYGOUS SPINK1 MUTATION-OWN EXPERIENCE. Dev Period Med. 2015 Jul-Sep;19(3 Pt 2):347-50.

Rygiel AM, Beer S, Simon P, Wertheim-Tysarowska K, Oracz G, Kucharzik T, Tysarowski A, Niepokój K, Kierkus J, Jurek M, Gawliński P, Poznański J, Bal J, Lerch MM, Sahin-Tóth M, Weiss FU. Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis. Hum Mutat. 2015 Mar;36(3):350-6.

Derix M., Kovacs P., Scholz M., Masson E., Chen JM., Ruffert C.,Lichtner P., Te Morsche R., Cavestro GM., PanEuropean Working Group on Alcoholic Chronic Pancreatitis members and collaborators, Claude Ferec, Drenth J, Witt H., Rosendahl J.Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic pancreatitis in a European replication study.Gut, 2015,64,1426-1433

Włodarczyk B., Borkowska A., Czupryniak L., Małecka-Panas E., Gąsiorowska A.Powstawanie zaburzeń gospodarki węglowodanowej w przebiegu raka gruczołowego trzustki (RT) i przewlekłego zapalenia trzustki (PZT)-ocena insulinemii i insulinooporności.Post Nauk Med., 2015, 28, 304-311

Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, Greenhalf W, Pasquali C, Hackert T, Fuchs CS, Mohelnikova-Duchonova B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello E, Zambon CF, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso HD, Hartge P, Strobel O, Małecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Souček P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin BM, Amundadottir LT, Canzian F. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer. 2015;137(9):2175-83

Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 2015;47(8):911-6.

Winter K., Szcześniak P., Bulska M., Kumor-Kisielewska a., Durko Ł., Gąsiorowska A., Orszulak-Michalak D., Małecka-Panas E.Serum level of Urokinase Plasminogen Activator (uPA) Correlates with the Survival of Patients with Pancreatic Ductal Adenocarcinoma (PDAC).Pancreatic Disorders & Therapy, 2015, 5, 3

Janiak A., Leśniowski B., Jasińska A., Pietruczuk M., Małecka-Panas E.Interleukin 18 as an early marker or prognostic factor in acute pancreatitis.Prz.Gastroenterol, 2015, 10, 4, 203-207

2014

Barbara Włodarczyk, Ludomir Stefańczyk, Ewa Małecka-Panas, Anita Gąsiorowska: Powikłania naczyniowe w przebiegu ostrego i przewlekłego zapalenia trzustki, Postępy Nauk Medycznych, t. XXVIII, nr 8B, 2015, s. 16-22

Oracz G, Cukrowska B, Kierkuś J, Ryżko J. Autoimmune markers in children with chronic pancreatitis. Prz Gastroenterol. 2014;9(3):142-6.

Kolodziejczyk E, Wejnarska K, Dadalski M, Kierkus J, Ryzko J, Oracz G. The nutritional status and factors contributing to malnutrition in children with chronic pancreatitis. Pancreatology. 2014 Jul-Aug;14(4):275-9.

Oracz G, Pertkiewicz J, Kierkus J, Dadalski M, Socha J, Ryzko J. Efficiency of pancreatic duct stenting therapy in children with chronic pancreatitis. Gastrointest Endosc. 2014 Dec;80(6):1022-9.

Talar-Wojnarowska R, Gąsiorowska A, Olakowski M, Dranka-Bojarowska D, Lampe P, Śmigielski J, Kujawiak M, Grzegorczyk J, Małecka-Panas E. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis. Advances in Medical Sciences 2014 (59): 288–292

Talar-Wojnarowska R., Gąsiorowska A., Olakowski M., Dranka-Bojarowska D., Lampe P., Kujawiak M., Grzegorczyk J., Małecka-Panas E.Utility of serum igG,IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.Adv.Med Sci., 2014

Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, Olson SH, Risch HA, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Austin MA, Barfield R, Basso D, Berndt SI, Boutron-Ruault MC, Brotzman M, Büchler MW, Bueno-de-Mesquita HB, Bugert P, Burdette L, Campa D, Caporaso NE, Capurso G, Chung C, Cotterchio M, Costello E, Elena J, Funel N, Gaziano JM, Giese NA, Giovannucci EL, Goggins M, Gorman MJ, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Henderson BE, Holly EA, Hu N, Hunter DJ, Innocenti F, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, LaCroix A, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Nakamura Y, Oberg AL, Owzar K, Patel AV, Peeters PH, Peters U, Pezzilli R, Piepoli A, Porta M, Real FX, Riboli E, Rothman N, Scarpa A, Shu XO, Silverman DT, Soucek P, Sund M, Talar-Wojnarowska R, Taylor PR, Theodoropoulos GE, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vodicka P, Wactawski-Wende J, Wentzensen N, Wu C, Yu H, Yu K, Zeleniuch-Jacquotte A, Hoover R, Hartge P, Fuchs C, Chanock SJ, Stolzenberg-Solomon RS, Amundadottir LT. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014;46(9):994-1000.

Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Delle Fave G, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas E, Mambrini A, Bambi F, Landi S, Pedrazzoli S, Bassi C, Pacetti P, Piepoli A, Tavano F, di Sebastiano P, Vodickova L, Basso D, Plebani M, Fogar P, Büchler MW, Bugert P, Vodicka P, Boggi U, Neoptolemos JP, Werner J, Canzian F. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis. 2013;45(2):95-9. 2014

2013

>Witt H, Beer S, Rosendahl J, Chen JM, Chandak GR, Masamune A, Bence M, Szmola R, Oracz G, Macek M Jr, Bhatia E, Steigenberger S, Lasher D, Bühler F, Delaporte C, Tebbing J, Ludwig M, Pilsak C, Saum K, Bugert P, Masson E, Paliwal S, Bhaskar S, Sobczynska-Tomaszewska A, Bak D, Balascak I, Choudhuri G, Nageshwar Reddy D, Rao GV, Thomas V, Kume K, Nakano E, Kakuta Y, Shimosegawa T, Durko L, Szabó A, Schnúr A, Hegyi P, Rakonczay Z Jr, Pfützer R, Schneider A, Groneberg DA, Braun M, Schmidt H, Witt U, Friess H, Algül H, Landt O, Schuelke M, Krüger R, Wiedenmann B, Schmidt F, Zimmer KP, Kovacs P, Stumvoll M, Blüher M, Müller T, Janecke A, Teich N, Grützmann R, Schulz HU, Mössner J, Keim V, Löhr M, Férec C, Sahin-Tóth M. Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet. 2013 Oct;45(10):1216-20.

Lipinski M, Rydzewski A, Rydzewska G. Early changes in serum creatinine level and estimated glomerular filtration rate predict pancreatic necrosis and mortality in acute pancreatitis Creatinine and eGFR in acute pancreatitis. Pancreatology. 2013 May-Jun;13(3):207-11.

Talar-Wojnarowska R, Pazurek M, Durko Ł, Degowska M, Rydzewska G, Śmigielski J, Janiak A, Olakowski M, Lampe P, Grzelak P, Stefańczyk L, Malecka-Panas E. Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions. Oncology Letters 2013; 5: 613-616

Gąsiorowska A, Talar-Wojnarowska R, Kaczka A, Borkowska A, Czupryniak L, Małecka-Panas E. Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer. Pancreatology. 2013; 13(4):409-14.

Śmigielski J., Piskorz Ł., Talar-Wojnarowska R., Malecka-Panas E., Jabłoński S., Brocki M.The estimation of metaloproteinases and their inhibitors blood levels in patients with pancreatic tumors.World J Surg Oncol., 2013, 11,137

Gąsiorowska A., Talar-Wojnarowska R., Kaczka A, Borkowska A., Czupryniak L., Małecka-Panas E.Role of adipocytokines and its correlation with endocrine pancreatic function in patients with pancreatic cancer.Pancreatology, 2013, 13, 409-414

Rizzato C., Campa D., Pezzilli R., Soucek P., Greenhalf W., Capurso G., Talar-Wojnarowska R., Heller A., Jamroziak K., Kay-Tee Khaw, Key T., Bambi F., Landi S., Mohelnikova-Duchonova B., Vodickova L., Buchler M., Bugert P., Vodicka P., Neoptolemos J., Werner J., Hoheisel J., Bauer A., Giese N., Canzian F.ABO groups and pancreatic cancer risk and survival:Results from the PANcreatic Disease Research (PANDoRa)consortium.Oncology Reports 2013, 29, 1637-1644